At Endo 2023, one of the most prominent endocrinology conferences, Bone Health Technologies presented pivotal trial data for its innovative product, Osteoboost. This novel treatment is designed to fight low bone mass in postmenopausal women. The technology, which received Breakthrough Device Status, has been filed for Class 2 Prescription De Novo Approval with the FDA. […]
Bone Health Technologies (BHT) is expanding its leadership team with the appointment of Dr. Pamela Peeke as its new Chief Medical Officer and board member, and the addition of Dr. Kian Beyzavi and Marcie Hamilton as new board directors. These appointments reflect BHT’s dedication to advancing the treatment of osteoporosis and osteopenia. Dr. Kian Beyzavi, […]
Bone Health Technologies (BHT), a leading innovator of technologies for improving bone health and preventing bone diseases, today announced that the United States Patent and Trademark Office (USPTO) has awarded its third patent for the OsteoBoost Vibration Belt. US patent no 11,219,542, covers the device consisting of one or more vibrating elements that are configured […]
